Mr Richard Steyn

UK Lung Cancer Coalition / University Hospitals Birmingham NHS Foundation Trust

Mr Richard Steyn, is a Consultant Thoracic Surgeon, Deputy Medical Director, University Hospitals Birmingham NHS Foundation Trust and Honorary Associate Professor, University of Warwick and the Chair of the UK Lung Cancer Coalition – the largest UK multi-interest group in lung cancer comprising leading lung cancer experts, senior NHS professionals, all key cancer charities, British Lung Foundation and healthcare companies. He is a member of the Thoracic Surgery sub-committee of the Society for Cardiothoracic Surgery of Great Britain and Ireland.

dont miss

Doubling Five-Year UK Lung Cancer Survival to 25% by 2025

The UK Lung Cancer Coalition (UKLCC) was set up in 2005 with the founding ambition of tackling poor survival outcomes and, specifically to double 5-year survival by 2015, which has now effectively been achieved (in England). The UKLCC is now calling for governments, commissioners and the health care community to re-double efforts and work together to raise 5-year rates to 25% by 2025 across the UK.

EVEN MORE SEMINARS

  • Professor Farzin Farzaneh: Speaking at the Oncology Convention

    Professor Farzin Farzaneh
    King’s College London

    Advanced Therapy Medicinal Products (ATMPs) for achievement of deeper and longer lasting immune mediated cancer remission

  • Corina van den Hurk: Speaking at the Oncology Convention

    Corina van den Hurk
    Netherlands Comprehensive Cancer Organisation

    Hair loss through chemotherapy is not inevitable!

  • Professor Zoë Winters: Speaking at the Oncology Convention

    Professor Zoë Winters
    University College London

    Is breast conserving surgery a future treatment for multiple ipsilateral breast cancers?

  • Andras Szasz: Speaking at the Oncology Convention

    Andras Szasz
    St. Istvan University

    Modulated electrohyperthermia (mEHT) for advanced malignant tumors

  • Joanne Edwards: Speaking at the Oncology Convention

    Joanne Edwards
    University of Glasgow

    Role of IKK alpha in Breast Cancer